chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Gets cramps in his fingers when doing surgery; Little pathology in the area of his rotator cuff; arm was very sore / remained sore / pain is now going down his arm / arm is still sore; Pain in his shoulder; Perhaps the administration of the vaccine was given in the wrong muscle; This case was reported by a other health professional via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st November 2019, the patient received the 1st dose of Shingrix (intramuscular). On 21st November 2019, unknown after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On 22nd November 2019, the patient experienced pain in arm and shoulder pain. On an unknown date, the patient experienced finger cramps and rotator cuff injury. On an unknown date, the outcome of the pain in arm and shoulder pain were recovering/resolving and the outcome of the finger cramps was not recovered/not resolved and the outcome of the rotator cuff injury and vaccine administered at inappropriate site were unknown.   The reporter considered the pain in arm to be related to Shingrix. It was unknown if the reporter considered the shoulder pain, finger cramps and rotator cuff injury to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced pain in arm, shoulder pain, finger cramps and rotator cuff injury after vaccination. The patient saw his doctor on 19th December 2019 who said perhaps the administration of the vaccine was given in the wrong muscle, which led to vaccine administered at inappropriate site. The patient was given some exercise, the exercises did not help so the patient returned to his doctor. The pain was now going down his arm and he gets cramps in his fingers when doing surgery. The patient referred to an orthopedic doctor who saw him and took x-rays and said there was a little pathology in the area of his rotator cuff. The patient was given an injection in the joint to help.  It has helped the pain in his shoulder but his arm is still sore even though it is a little better. The physician wanted advice on whether he should get the 2nd dose.
I started feeling feverish and achy in the evening, and then overnight my arm started to feel warm and itchy around the injection site. By morning it was severely swollen and painful, with a large red rash. I checked my temperature in the morning and it was 98.3, but at the site of the injection the thermometer read 102.1. I called my insurance carrier's nurseline to see if I needed to seek medical treatment, and she advised that this was a known issue with the Moderna vaccine, and would recommend seeking treatment if it gets worse or I start to get a fever over 100.  I've been taking ibuprofen and benedryl for the itching.  It's still red, swollen, and painful.  A coworker suggested that I report the reaction to this site.
Hep A vaccine given by mistake. Provider had ordered Hep B to be given. Pt was called by provider to make sure she was doing well and she was. Another appt was made for pt to come back in to receive the right vaccine.
Heat slightly below area of injection; Rash slightly below area of injection; Redness slightly below area of injection; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Heat slightly below area of injection), RASH (Rash slightly below area of injection) and ERYTHEMA (Redness slightly below area of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 012M204) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid nodule since 1992. Concomitant products included LEVOTHYROXINE for Thyroid nodule, CENTRUM SILVER WOMEN 50+, ZINC, NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMIN-B COMPLEX), BIOTIN, VITAMIN D NOS, ACETYLSALICYLIC ACID (ASPIRIN 81) and PSYLLIUM HUSK [PLANTAGO OVATA HUSK] for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Heat slightly below area of injection), RASH (Rash slightly below area of injection) and ERYTHEMA (Redness slightly below area of injection). On 05-Mar-2021, FEELING HOT (Heat slightly below area of injection), RASH (Rash slightly below area of injection) and ERYTHEMA (Redness slightly below area of injection) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was provided by the reporter.      Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Non significant Information updated.
My left arm became red, swollen, itchy and hot to the touch eight days after receiving the Moderna vaccine.  The red area was approximately 8" long by 4" wide and was on my upper arm around the location of the injection site.  I treated it with lynocaine and aloe to relieve the itching.  After 2 days the swelling started to go down but the redness looked more like a rash.  It took about 6 days for it to completely go away.  I did not seek medical attention during the event and I have had no further problems.
Pt has red circle about size of dime in area of injection, was red and hot to touch per him,  he came in 10/18/19 to inform us of reaction.  He stated he went to doctor who stated it was a fungal issue in area, they gave clotrimazole cream to treat per his information, still ongoing rash in area
This spontaneous report was received from a medical clinic supervisor referring to a 26 year old female patient. The patient's concomitant medications included ibuprofen(IBUPROFEN), valacyclovir hydrochloride and atovaquone, chloroguanide hydrochloride(MALARONE). The patient had none pertinent medical history or drug reactions/allergies. On 14-JAN-2019, the patient received a dose of PNEUMOVAX 23 (lot # R018735 with expiration date 06-APR-2020; strength and dose were not provided) intramuscularly and AFLURIA during the same office visit for prophylaxis. Since 14-JAN-2019 (reported as since receiving the vaccinations), the patient reported that she had developed dry mouth. On an unknown date in January 2019 (reported as now),  the patient's arm (right deltoid) was red and swollen. The patient had also developed a fever on an unknown date in January 2019, but no pus had drained from the injection site. The physician suggested going to an unidentified emergency room, but the patient declined. Sulfamethoxazole, trimethoprim(BACTRIM DS) and cephalexin were prescribed. The patient performed none lab diagnostics/studies. The outcome of the events was reported as not recovered. The causality between PNEUMOVAX 23 and the events was not provided.
11/02/2021 date I had the Moderna booster vaccine. 11/03/2021 date I started feeling kind of weird then a couple days later , after continuing to feel bad each day after I was hospitalized due to myocardial, bell's palsy, psychosis, severe headaches, body aches, pain in my heart/chest, rash on my neck, fever, my arm I had the shot in has felt like it's constantly burning,fire,like rope burns since then. Since Nov 2nd 2021 that I received the Moderna booster Vaccine my health has went from completely healthy to being hospitalized again with Cancer. All due to this booster vaccine I took.
Patient came in 2 days after I gave her FLUAD flu shot. She had redness and warmth on the medial side of her arm, opposite of her deltoid muscle.
PATIENT FAINTED AS SOON AS SHE RECEIVED THE VACCINE. SHE GAINED CONSCIOUSNESS WITHIN 15 SECONDS BUT COMPLAINED THAT HER VISION WAS AFFECTED AND SHE COULDN'T SEE CLEARLY. SHE LOOKED PALE. DAD CALLED EMERGENCY AND THE PARAMEDICS ARRIVED AND TOOK EHR VITALS. THEY WAITED A FEW MORE MINUTES AND CHECKED HER VITALS AGAIN. SHE SEEMED TO HAVE RECOVERED BUT THE DAD WANTED TO TAKE HER TO THE DOCTOR'S OFFICE
Information has been received from a registered nurse (R.N.) concerning a 4-year-old male with no medical history and allergies who on 24-JUN-2003 was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot# 641161/0796M).  Concomitant therapy included loratadine (CLARITIN) and was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Winstar RA 27/3) (manufacturer unknown) on 24-JUN-2003. On 05-NOV-2006 the patient developed an itchy rash with fever and malaise. Unspecified medical treatment was sought, no laboratory or diagnostic treatments were performed. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
It appears vaccine was administered in the wrong location, not in the deltoid, probably SQ. She has swelling, redness, warmth midway between the elbow and shoulder. I can see puncture site in the reddened area.
Pt was seen in ER on 12/29/07 after developing urticaria. Pt had received immunizations on 12/28/07. Pt received Benadryl. Came into office on 12/31 mom stating urticaria resolved, but child was fussy and mom noticed eyes and hands were still swollen. Pt given Pediapred and symptoms resolved.
This spontaneous report was received from a pharmacist via a company representative refers to an over the age of 60 year old Adult male patient. Concurrent conditions, medical history and allergies were not reported. On an unspecified date in February 2015, the patient was vaccinated with a dose of ZOSTAVAX, (strength, dose, frequency, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant therapies were not reported. On an unknown date in 2015 (reported as "recently"), the patient experienced injection site pain which was described as "deep tissue soreness". The patient sought medical attention on an unspecified date. There was unspecified if treatment was given for the adverse event and if lab diagnostics studies were performed. The outcome of injection site pain was reported as recovered/resolved on an unknown date in 2015. The relatedness between injection site pain and therapy with ZOSTAVAX was not reported. Additional information has been requested.
This case was reported by a consumer and described the occurrence of injection site itching over arm in a 74-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). A physician or other healthcare professional has not verified this report. On the morning of 4 February 2013 the subject received a dose of BOOSTRIX (.5 ml, unknown route, right arm). On the morning of 4 February 2013, within hours of vaccination with BOOSTRIX, the subject experienced injection site itching over arm. The subject described "itchiness on top of right arm (vaccinated arm)." At the time of reporting, no treatment had been rendered. At the time of reporting the outcome of the event was unspecified.
Patient complained of intermittent nausea for approximately 15 minutes after receiving second covid vaccine. Patient was observed for 35 minutes with full resolution of symptoms.
Local reaction, starting within 24 hours of vaccine, with 2" red, warm and swollen area at vaccine injection site on right leg.
redness in left arm; swelling in left arm; itching in left arm; numbness from shoulder down to 2 fingers but mainly had the numbness in her upper arm; hives around both wrists and joints and knees; This is a spontaneous report received from a contactable consumer (patient husband) via a Pfizer sponsored Programme. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: ER8731, Expiration date: Unknown) via an intramuscular route, administered in left shoulder (left arm) on 04May2021 at 8:15 (at the age of 38-year-old) at a single dose for covid-19 immunization at public health department. Patient medical history included seasonal allergies, illness at time of vaccination was overweight. Patient had reactions to flu shots in the past, not hives but her immune system gets ramped up; just like the normal side effects being a little bit more for her and had like a natural allergic reaction and she had a reaction to cat hair. Concomitant medications were not reported. Patient had no history of previous immunization with the Pfizer vaccine. The patient did not receive additional vaccines on same date of the Pfizer Suspect. The patient did not receive prior vaccinations within 4 weeks. On 04May2021, after got shot the patient experienced redness, swelling, itching in the left arm. She also experienced numbness from her shoulder all the way down to two of her fingers, but mainly had the numbness in her upper arm. These symptoms were what she initially got and then it evolved over the 12-24 hours after receiving the shot, patient was developed with hives around both wrists and joints and knees. Patient received Benadryl as a treatment for the events. The events did not result in emergency or physician room. She did not have any problems of breathing or anything like that. Patient was consulted by doctor and stated no reason to have blood work or tests or anything. She had the numbness for about 24 hours and the hives resolved after about 48 hours. The outcome of events numbness from her shoulder all the way down to two of her fingers, but mainly had the numbness in her upper arm, hives around both wrists and joints and knees was recovered on an unspecified date in May2021, and the rest of the events was unknown. Reporter wants to know how patient will be authorized to get the second shot.  Follow-up attempts are needed. Additional information has been requested.
5 from Moderna that had similar reaction hives the whales/In some cases had another similar reaction where they had the hives, the welts/The hives reappeared; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (5 from Moderna that had similar reaction hives the whales/In some cases had another similar reaction where they had the hives, the welts/The hives reappeared) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (5 from Moderna that had similar reaction hives the whales/In some cases had another similar reaction where they had the hives, the welts/The hives reappeared). At the time of the report, URTICARIA (5 from Moderna that had similar reaction hives the whales/In some cases had another similar reaction where they had the hives, the welts/The hives reappeared) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Case contains information of 3 of 5 patients reported.  Concomitant products were not reported.  It was reported that it was whether patient had any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that a total of 12 patients on a study based on 7 from Pfizer and 5 from Moderna that had similar reaction hives the whales. And that they proceeded to get another vaccine. In some cases had another similar reaction where they had the hives, the welts. But they At the time when they had them they took an antihistamine and relieved it. It was just resolved simply by taking an antihistamine. The hives reappeared. They didn't have any respiratory problems. They didn't have any cardiac problems, which was good.   This case was linked to US-MODERNATX, INC.-MOD-2023-710286 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-710286:Master case (1 of 5 patient)
Nurse Practitioner Family Medicine    COVID VACCINE CLINIC 2/12/2021    Patient:                                                                    Date:  2/12/2021                                                                                             Subjective Patient is a 33 y.o. female who was seen at COVID Vaccine Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience itching at vaccine site.  She denied difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to increased swelling, rapid progression of symptoms, skin changes and tongue swelling.         ALLERGY REVIEW OF SYSTEMS:  Patient complains of itching of skin   Patient denies facial swelling, sore throat, frequent throat clearing, chest tightness, shortness of breath and wheezing       Previous Reactions: adhesive reactions.     Objective    Vitals Vitals:   02/12/21 1155 BP: 130/85 Pulse: (!) 108 SpO2: 100%        Physical Exam Nursing note reviewed.  Constitutional:      General: She is not in acute distress.    Appearance: Normal appearance. She is well-developed. She is not diaphoretic.  HENT:     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.  Eyes:     Pupils: Pupils are equal, round, and reactive to light.  Neck:     Thyroid: No thyromegaly.  Pulmonary:     Effort: Pulmonary effort is normal.  Skin:    General: Skin is warm and dry.     Comments: Slight irritation noted around the adhesive location of band-aid.   Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.        Assessment/Plan  Treatment included: antihistamines Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Local reaction (arm pain, bleeding/bruising, mechanical irritation, localized rash)   Encouraged for her to avoid adhesives. Adhesive reaction added to allergy list.
0.5 cc of Novartis lot #102127P1 influenza (H1N1) vaccine was given in L deltoid location, no blood aspirated prior to injection. Immediately about 1 inch and 1/4 sized bump at injection site noted. Patient denies pain or heat. Vitals taken, pt kept for 20 minutes for aspiration.
Time listed above is approximate.  Started having allergic reactions the day of the injection. Arm swelled up to twice its size, had a bright red knot on arm the size of a golfball, very painful, sugar went up, had low grade fevers on and off for the past month or so. The most frightening reaction was when I laid down to sleep I suddenly couldn't breathe and my chest was wheezing very loud. Coughed continually from 11 PM to 4 AM. It keeps cropping back up. Had another episode last night (12/30), was so bad, I almost called 911 because I couldn't get any oxygen.
PT IS ONLY 63 Y/O AND REQUESTED THE HIGH-DOSE FLU VACCINE INDICATED FOR 65+. FLOAT PHARMACIST WORKING AT THE TIME VERIFIED AND ADMINISTERED THE VACCINE. PT HAS NOT REPORTED ANY ADVERSE EVENTS YET. I CALLED THE PT AND HE DID NOT COMPLAIN OF ANY ADVERSE EFFECTS. PT DID STATE HE SPECIFICALLY REQUESTED HIGH DOSE VACCINE DUE TO HAVING MULTIPLE COMORBIDITIES AND WANTING 'EXTRA PROTECTION'. DESPITE NO ADVERSE EVENTS BEING REPORTED, I AM FILLING THIS OUT TO COVER ALL BASES AND BE THOROUGH.
Anxious, tingling, heart racing, throat closing. Pt was given 25 mg IM. Pt started feeling within 15 mins. PT vitals returned to normal within 10 mins. Pt discharged home with friend.
This spontaneous report was received from a healthcare worker concerning two patients of unknown age and gender. Medical history, concomitant therapies and concurrent conditions were not reported. On unknown dates improperly stored doses of VARIVAX lot # M004326, Exp. date 25-JAN-2018 had been administered. Dose, route, anatomical location and dose number were not reported. It was reported that, on an unknown date, the refrigerator was out of range for 9 hours, with a highest temperature of 19 degrees F. The healthcare worker reported that vaccines had been administered before the excursion was identified. No prior temperature excursions were reported. No adverse events were reported. No product quality complaint was involved. At the time of reporting the outcome of the event was unknown. Additional information has been requested.
Large baseball size welt at injection site. Patient stated it was hot to touch, did not hurt or itch.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 26-AUG-2010, the patient was inoculated with the ZOSTAVAX (lot number, dosage, and route of administration not provided) by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2015, the patient was treated by the physician for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Tested positive for COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable other healthcare professional reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 15Jan2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that, healthcare professional (HCP) caller was calling on behalf of her patient. Patient received the first dose on 15Jan2021 but tested positive for COVID on the 20Jan2021 and the patient was scheduled tomorrow for the 2nd dose. Caller wants to know if the patient can still take the 2nd dose. HCP caller said several patients experienced after taking first dose they would be tested positive for COVID then they would take monoclonal antibody infusion to reduce the risk of complications. HCP wants to clarify if they should take the 2nd dose. The caller said her first patient got the first dose of vaccine then got tested positive, then the call got disconnected. The outcome of the event was unknown.